When a parent company history includes fraud convictions related to pharmaceutical manufacturing and distribution, it raises legitimate questions about the culture of compliance that extends to subsidiaries
Maintenance Dosing and Long-Term Use Once you reach your target maintenance dose, typically 2.0 to 2.4 mg, you continue that same dose every seven days indefinitely as long as you remain in treatment
Indications and Usage Ozempic (semaglutide) tablets 4 mg or 9 mg and Rybelsus (semaglutide) tablets 7 mg or 14 mg are indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events Important Safety Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
Risk of bias assessment for blinding of participants and personnel, incomplete outcome data, selective reporting, and overall risk of bias are for the primary outcome (change in HbA1c)
Recent studies noting an increased incidence of cholecystitis with GLP-1 use have made providers more vigilant